Glioblastoma
Glioblastoma is a highly aggressive type of brain tumor that arises from glial cells, often leading to rapid progression of symptoms and requiring urgent medical attention.
Glioblastoma: L19TNF and Lomustine Study
We are evaluating a new treatment combining L19TNF with lomustine for patients with glioblastoma at their first progression. This study aims to understand how safe and effective this combination is.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Hospital Pierre Wertheimer
Neuro Oncology
Bron, France
Hopital Saint Louis
Neurology
Quinze-Vingts, France
Hopital Universitaire Pitie Salpetriere
Neurologie 2/ Neuro-oncologie
Salpêtrière, France
Sponsor: Philogen S.p.A.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.